Australia Ultrasound Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Australia Ultrasound Devices Market Trends and Insights

Burden of Chronic & Lifestyle Diseases

Chronic cardiovascular, musculoskeletal, and oncologic conditions are increasing alongside an aging population, heightening ultrasound demand in every state. AI-enhanced workflows now shorten scan-to-report times, crucial where sonographer shortages delay appointments. Mobile systems further support community screenings, reducing the need to refer patients for costly CT or MRI. As over-65 citizens are projected to rise 60% by 2030, scalable diagnostic capacity becomes a policy imperative. Vendors that bundle preventative-care training with equipment sales benefit from this demographic burden.

Rapid Adoption of POCUS in Primary Care & Ambulances

Point-of-care ultrasound is migrating from emergency departments to general practice. Rural clinicians who completed structured courses reported a 22% knowledge gain and 62% clinical utilisation within six months. The Northern Territory’s tele-sonography initiative links paramedics with hospital specialists via live video, proving lifesaving in obstetric emergencies. Despite clear utility, diffusion is tempered by practice cultures that prefer specialist referral and by reimbursement rules that still mandate on-site supervision for Medicare rebates.^{[1]Australian Government Department of Health, “Medicare Benefits Schedule Note IN.0.13,” health.gov.au}Evidence-generation studies underway aim to clarify billing pathways and further legitimise POCUS in primary settings.

Miniaturization & AI-Assisted Imaging Workflow

Silicon-based micro-electro-mechanical (MEMS) transducers now enable a single handheld probe to cover multiple frequencies, shrinking hardware footprints while maintaining image fidelity.^{[2]IEEE Spectrum, “Ultrasound on a Chip Promises All-Purpose Scanners,” spectrum.ieee.org}Algorithms automate beam-forming and anatomical measurements so entry-level users can capture diagnostic-quality scans, directly addressing Australia’s workforce shortfall. GE Healthcare teamed with NVIDIA in 2025 to virtualise probe training, accelerating AI deployment without on-patient experimentation. Sports-medicine clinics already rely on augmented guidance to visualise tendon injuries, signalling that AI lowers skill barriers beyond hospital walls.

Government “Buying Australian Made” Procurement Push

Canberra’s Future Made in Australia Act encourages public buyers to award contracts that deliver domestic economic value. The Australian Medtech Manufacturing Centre committed USD 20 million to bolster local device production capacity, with ultrasound components listed among priority categories. Import dependence still covers 80% of ultrasound hardware, making immediate reshoring unrealistic. Yet vendors that assemble or service units locally secure preferential scoring in public tenders, as seen when Victorian hospitals shortlisted suppliers demonstrating local content compliance. Over time, these criteria could redistribute market share toward partnerships that embed manufacturing or R&D functions in Australia.

Reimbursement Uncertainty for Handheld Scans

Medicare note IN.0.13 requires specialist supervision for many ultrasound rebates, leaving handheld POCUS scans by general practitioners unfunded outside hospital walls. This limits private adoption even where clinical benefit is proven. Private insurers have not yet standardised handheld coverage, instead approving claims case-by-case. Upcoming Health Technology Assessment reforms promise conditional funding pathways, but evidence dossiers and price-volume agreements will take time to assemble. For rural GPs, the absence of clear billing codes remains the chief obstacle to investment.

Sonographer Workforce Shortages

Just 7,780 accredited sonographers were practicing nationwide in 2023, leaving an estimated 3,000-person gap that lengthens appointment wait times and inflates salaries.^{[3]Australasian Sonographers Association, “Workforce Report 2024,” sonographers.org} Only 25% of practitioners work under formal regulation, complicating quality assurance and inter-state mobility. Clinical-placement shortages hinder student throughput, especially in private clinics where supervision depresses productivity. The cascading effect pushes some providers toward CT or MRI referrals, raising system costs. AI-driven automation may ease strain, but credentialing bodies still require human oversight for final reports.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Application: Obstetrics Maintains Dominance while Anesthesiology Surges

Obstetrics and gynecology retained a 21.95% share of the Australia ultrasound devices market in 2025, reflecting universal antenatal screening guidelines and the popularity of 3D fetal imaging packages in private clinics. The segment continues to generate steady unit sales as expectant parents opt for elective 4D keepsake scans that require advanced transducers. Rising maternal age also drives high-risk screenings, favoring cart-based systems with sophisticated workflow modules.

Anesthesiology is forecast to expand at a 5.69% CAGR, the fastest among clinical uses, as regional-block techniques increasingly rely on ultrasound guidance for safety. Emergency departments and day-surgery centers are retrofitting procedure rooms with portable systems capable of vascular access, nerve mapping, and post-operative lung checks. The Australia ultrasound devices market size for anesthesiology is therefore set to climb more quickly than radiology purchases, though overall revenue remains smaller in absolute terms.

By Technology: 3D Leadership Faces HIFU Innovation

Three-dimensional and four-dimensional imaging captured 42.98% of the Australia ultrasound devices market size in 2025, benefiting from obstetric and cardiology demand for volumetric assessment and post-processing analytics. Vendors differentiate through ergonomic probe designs and real-time rendering, which shorten scan times.

High-intensity focused ultrasound commands just a niche share today but shows 5.19% CAGR potential thanks to non-invasive tumor ablation for uterine fibroids and prostate applications. Hospitals trialling HIFU note shorter patient recovery times versus surgery, indicating broader adoption once capital budgets align. Traditional 2D diagnostic systems will persist in rural settings because of low cost, but advanced modalities appear poised to capture incremental spend.

By Portability: Stationary Platforms Hold Ground while Handheld Devices Disrupt

Stationary consoles accounted for 65.74% of the Australia ultrasound devices market share in 2025, anchored by radiology and cardiology departments that need premium image quality for complex cases. Five-year replacement cycles and bundled service contracts help vendors secure recurring revenue.

Handheld probes, however, show a rapid 7.01% CAGR as clinicians seek bedside diagnostics and telemedicine integration. Device makers that couple hardware with subscription-based cloud storage report faster penetration in general practice where IT budgets are lean. The continuum of portability therefore grows stratified: high-end carts for tertiary centers, mid-range mobiles for regional hospitals, and pocket devices for field use.

By End User: Public Hospital Scale Meets Private-Hospital Agility

Public hospitals captured 38.85% of expenditure by virtue of their role in trauma, obstetrics, and oncology pathways. Multi-modality procurement frameworks boost negotiation leverage, yet tender scope favors full-line manufacturers that supply service and training.

Private hospitals grew at 6.49% CAGR on pent-up elective procedures and investments in same-day surgery. While the segment remains smaller than the public block, its faster pace offers suppliers attractive upsell opportunities. Specialist clinics and physiotherapy centers also scale purchases of lightweight devices, encouraged by financing schemes that spread costs over usage-based periods.

Geography Analysis

Metropolitan states dominate volume, with New South Wales, Victoria, and Queensland accounting for more than 70% of installed capacity. Sydney’s integrated e-Health record platform drives centralized imaging archives that favor console replacements aligned with network upgrades. Melbourne hospitals leverage state-led procurement panels, compressing vendor shortlists but guaranteeing order visibility over multi-year spans.

Regional markets reveal contrasting patterns. The Northern Territory Tele-Sonography program pioneered live cardiac scanning across 500 km distances, proving demand for robust portable units in remote indigenous communities. Western Australia pilots similar models where fly-in clinicians operate battery-powered probes during outreach camps. Tasmania and the Australian Capital Territory add smaller but technology-savvy pockets. Hobart’s Royal Hospital upgraded to AI-enabled cart systems in 2024 to address staffing gaps. Canberra focuses on defence-aligned trauma research, integrating ultrasound with rapid-response protocols. Geography therefore shapes both specification and service models, demanding versatile supplier portfolios.

Regulatory Landscape

Ultrasound systems supplied in Australia are regulated by the Therapeutic Goods Administration (TGA) under the Therapeutic Goods (Medical Devices) Regulations 2002, and must be included on the Australian Register of Therapeutic Goods (ARTG) before supply. Diagnostic ultrasound platforms are generally treated as active medical devices (commonly Class IIa) and must demonstrate compliance with the Essential Principles (Schedule 1), including risk management and safety for energy-emitting devices.

Market access typically runs through a sponsor responsible for ARTG inclusion, conformity assessment evidence, and ongoing post-market obligations. The Australian Regulatory Guidelines for Medical Devices (ARGMD) set expectations for evidence, labeling, vigilance reporting, and traceability, which becomes more material as software-enabled features (including AI workflow tools) expand and require additional documentation and lifecycle controls.

Market Opportunities and Future Outlook

Near-term whitespace in Australia centers on expanding point-of-care ultrasound (POCUS) beyond emergency departments into general practice, ambulance services, and remote care models. In these settings, portability and simplified workflows help reduce reliance on scarce sonography capacity. The Northern Territory tele-sonography initiative highlighted in the report context (linking paramedics with hospital specialists via live video) points to continued demand for rugged, connected devices, alongside vendor-provided training, protocol libraries, and quality assurance services that can function across long distances.

A second opportunity sits in localization and service footprint, given the report-context import dependence (about 80% of ultrasound hardware) and procurement emphasis on domestic economic value. Programs such as the Future Made in Australia Act and the Australian Medtech Manufacturing Centre commitment of USD 20 million create openings for suppliers that add Australian-based assembly, probe repair, cybersecurity support, and clinical application training. On commercialization, reimbursement pathways remain a gating factor for handheld scanning in private practice, so vendors that produce indication-specific evidence packages and support providers navigating Medicare Benefits Schedule constraints can help accelerate adoption in primary care and specialist clinics despite funding uncertainty.